Overview
Product nameTreponema pallidum p17 protein
Protein descriptionRecombinant fragment. The protein contains the Tr.pallidum p17 immunodominant regions.
Expression hostE. coli
Properties
Purity> 90
% by SDS-PAGE
Purification notesInclusion bodies.
Biological activityImmunoreactive with sera of Tr.pallidum - infected individuals.
FormLiquid
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Storage bufferPreservative: None
Constituents: 8M Urea, 10mM Tris HCl, 1mM EDTA, 1mM DTT, pH 8
Concentration information loading...
Research Areas
Applications
Our Abpromise guarantee covers the use of
ab43053
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|
Application
|
Notes |
| ELISA |
|
| WB |
|
Application notesELISA: Use at an assay dependent dilution.
WB: Use at an assay dependent dilution.
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
Protein info
RelevanceSyphilis is a chronic, complex sexually transmitted disease of humans caused by the spirochetal bacterium Treponema pallidum. Primary syphilis is characterized by the prevalence of IgG to protein p41 with the total antibody level being low, while early latent syphilis is characterized mainly by prevalence of IgG to protein p17 in the presence of high titers of antibodies.
Cellular localizationCell Membrane
References for Treponema pallidum p17 protein (ab43053)
ab43053
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
